{"transactions":[{"id":863919,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-03-04T21:34:56.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 4, 2026, with a grant date of March 2, 2026 (the \"Grant Date\"), and represents the Reporting Person's annual equity award for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":5.35,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001965071-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000196507126000002/ownership.xml","form_type":"4"}},{"id":1224991,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T21:29:57.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 13, 2025, with a grant date of March 3, 2025 (the \"Grant Date\"), and represents the Reporting Person's annual equity award for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":165000,"derivative":{"exercise_price":2.46,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0000950170-25-033675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025033675/ownership.xml","form_type":"4"}},{"id":1471495,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-24T20:07:04.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship."}],"balance_after":150000,"derivative":{"exercise_price":10.65,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-076710","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024076710/ownership.xml","form_type":"4"}},{"id":1670309,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-26T22:40:04.000Z","date":"2024-01-24","kind":"purchase","planned":false,"acquired":true,"shares":280000,"price":0.4996,"value":139888.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4871 to $0.5000, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":1375425,"source":{"system":"sec-edgar","filing":"0001437749-24-002324","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002324/rdgdoc.xml","form_type":"4"}},{"id":1706176,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:09:04.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":0.3425,"value":137000.0,"ownership":{"direct":true},"balance_after":1095425,"source":{"system":"sec-edgar","filing":"0001437749-23-034931","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034931/rdgdoc.xml","form_type":"4"}},{"id":1706175,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:09:04.000Z","date":"2023-12-18","kind":"purchase","planned":false,"acquired":true,"shares":60419,"price":0.2559,"value":15461.2221,"ownership":{"direct":true},"balance_after":695425,"source":{"system":"sec-edgar","filing":"0001437749-23-034931","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034931/rdgdoc.xml","form_type":"4"}},{"id":1706174,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T00:09:04.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":135006,"price":0.2687,"value":36276.1122,"ownership":{"direct":true},"balance_after":635006,"source":{"system":"sec-edgar","filing":"0001437749-23-034931","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034931/rdgdoc.xml","form_type":"4"}},{"id":1711788,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63025,"kind":"person","name":"Puhlmann Markus","position":1,"cik":"0001965071","reported_name":"Puhlmann Markus","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-14T23:44:17.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":1477619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested."}],"balance_after":2885688,"derivative":{"exercise_price":0.24,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":1477619},"source":{"system":"sec-edgar","filing":"0001437749-23-034481","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034481/rdgdoc.xml","form_type":"4"}}]}